Trevor Pickersgill

4.3k total citations · 1 hit paper
26 papers, 835 citations indexed

About

Trevor Pickersgill is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Trevor Pickersgill has authored 26 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 8 papers in Rheumatology and 4 papers in Neurology. Recurrent topics in Trevor Pickersgill's work include Multiple Sclerosis Research Studies (20 papers), Systemic Sclerosis and Related Diseases (8 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Trevor Pickersgill is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), Systemic Sclerosis and Related Diseases (8 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Trevor Pickersgill collaborates with scholars based in United Kingdom and Italy. Trevor Pickersgill's co-authors include Neil P. Robertson, Katharine Harding, Mark Wardle, Claire Hirst, Gillian Ingram, Valentina Tomassini, Emma Tallantyre, Fady Joseph, Mark Willis and M. Cossburn and has published in prestigious journals such as Brain, Neurology and BMJ.

In The Last Decade

Trevor Pickersgill

25 papers receiving 818 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

2019 227 citations Katharine Harding, Owain Williams et al. profile →

Peers

Trevor Pickersgill

PFM

NEURO

RHEUM

ONCOL

IMMUN

Leszek Stawiarz Sweden

Mark Wardle United Kingdom

Mary Rensel United States

V. Devonshire Canada

Giovanni Bosco Zimatore Italy

Adriana Carrá Argentina

Björn Runmarker Sweden

Alexander Musallam United States

D Goodkin United States

David Magalashvili Israel

Leszek Stawiarz Sweden

Trevor Pickersgill

740 ×1.1

PFM

274 ×1.2

NEURO

266 ×1.7

RHEUM

118 ×0.9

ONCOL

122 ×1.1

IMMUN

Citations per year, relative to Trevor Pickersgill Trevor Pickersgill (= 1×) peers Leszek Stawiarz

Countries citing papers authored by Trevor Pickersgill

Since Specialization

Citations

This map shows the geographic impact of Trevor Pickersgill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trevor Pickersgill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trevor Pickersgill more than expected).

Fields of papers citing papers by Trevor Pickersgill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trevor Pickersgill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trevor Pickersgill. The network helps show where Trevor Pickersgill may publish in the future.

Co-authorship network of co-authors of Trevor Pickersgill

This figure shows the co-authorship network connecting the top 25 collaborators of Trevor Pickersgill. A scholar is included among the top collaborators of Trevor Pickersgill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trevor Pickersgill. Trevor Pickersgill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Harding, Katharine, Gillian Ingram, Emma Tallantyre, et al.. (2022). Contemporary study of multiple sclerosis disability in South East Wales. Journal of Neurology Neurosurgery & Psychiatry. 94(4). 272–279. 4 indexed citations

2.

Pickersgill, Trevor. (2022). Covid-19: Ending free testing is a mistake. BMJ. 377. o936–o936.

3.

Harding, Katharine, Valerie Anderson, Owain Williams, et al.. (2018). A contemporary study of mortality in the multiple sclerosis population of south east Wales. Multiple Sclerosis and Related Disorders. 25. 186–191. 9 indexed citations

4.

Tallantyre, Emma, Fady Joseph, Valentina Tomassini, et al.. (2018). How common is truly benign MS in a UK population?. Journal of Neurology Neurosurgery & Psychiatry. 90(5). 522–528. 20 indexed citations

5.

Anderson, Valerie, Katharine Harding, Fady Joseph, et al.. (2018). Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis. Multiple Sclerosis Journal. 24(13). 1786–1787. 20 indexed citations

6.

Harding, Katharine, Kate Tilling, Mark Willis, et al.. (2017). Seasonal variation in multiple sclerosis relapse. Journal of Neurology. 264(6). 1059–1067. 28 indexed citations

7.

Willis, Mark, Trevor Pickersgill, Neil P. Robertson, et al.. (2016). Alemtuzumab-induced remission of multiple sclerosis-associated uveitis. International Ophthalmology. 37(5). 1229–1233. 11 indexed citations

8.

Williams, Owain, Katharine Harding, Mark Willis, et al.. (2015). DISEASE MODIFYING TREATMENTS IN MS: INDUCTION OR ESCALATION?. Journal of Neurology Neurosurgery & Psychiatry. 86(11). e4.117–e4. 1 indexed citations

9.

Tallantyre, Emma, et al.. (2014). The aetiology of acute neurological decline in multiple sclerosis: Experience from an open-access clinic. Multiple Sclerosis Journal. 21(1). 67–75. 13 indexed citations

10.

Harding, Katharine, Mark Wardle, Perry Moore, et al.. (2014). Modelling the natural history of primary progressive multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 86(1). 13–19. 31 indexed citations

11.

Harding, Katharine, Mark Willis, Mark Wardle, Trevor Pickersgill, & Neil P. Robertson. (2014). NO TEMPORAL EFFECT ON DISABILITY IN MULTIPLE SCLEROSIS. Journal of Neurology Neurosurgery & Psychiatry. 85(10). e4.2–e4. 1 indexed citations

12.

Harding, Katharine, et al.. (2013). Demographic and clinical factors associated with changes in employment in multiple sclerosis. Multiple Sclerosis Journal. 19(12). 1647–1654. 114 indexed citations

13.

Harding, Katharine, Samantha Loveless, Mark Wardle, et al.. (2013). EPISTATIC EFFECTS ON THE PHENOTYPE OF MULTIPLE SCLEROSIS. Journal of Neurology Neurosurgery & Psychiatry. 84(11). e2.146–e2. 2 indexed citations

14.

Hirst, Claire, et al.. (2012). Multiple sclerosis relapses and depression. Journal of Psychosomatic Research. 73(4). 272–276. 63 indexed citations

15.

Harding, Katharine, M. Cossburn, Gillian Ingram, et al.. (2012). Long-term outcome of paediatric-onset multiple sclerosis: a population-based study. Journal of Neurology Neurosurgery & Psychiatry. 84(2). 141–147. 89 indexed citations

16.

Harding, Katharine, Gillian Ingram, M. Cossburn, et al.. (2012). Genotype–phenotype correlation for non-HLA disease associated risk alleles in multiple sclerosis. Neuroscience Letters. 526(1). 15–19. 4 indexed citations

17.

Ingram, Gillian, Svetlana Hakobyan, Claire Hirst, et al.. (2010). Complement regulator factor H as a serum biomarker of multiple sclerosis disease state. Brain. 133(6). 1602–1611. 73 indexed citations

18.

Pickersgill, Trevor. (2004). A career in neurology. BMJ. 329(7465). s93.2–s94. 1 indexed citations

19.

Morrison, Rory, et al.. (2004). Transient femoral neuropathy after harvest of bone from the iliac crest. British Journal of Oral and Maxillofacial Surgery. 42(6). 572–574. 9 indexed citations

20.

Pickersgill, Trevor. (2003). Specialist registrars acting up as consultants. BMJ. 327(7418). 107s–108. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact